SUBSCRIBE
SUBSCRIBE
News   Business

Astellas Reports The First Nine Months Financial Results Of FY2016

January 31, 2017 | 
1 min read
TOKYO--(BUSINESS WIRE)--Astellas Pharma Inc. (TOKYO: 4503) (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced financial results for three quarters of fiscal year 2016 ending March 31, 2017 (“FY2016”).
Earnings Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Business people shaking hand in China.
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
January 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Array of piggy banks in saturated colours on high colour contrast background. Illustration of the concept of bank savings, financial investment and multiple sources of income
Insights
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
January 29, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker
Water tap dripping dollar bills on gray background. Business and financial success concept. 3D Rendering
IPO
Eikon, Veradermics, Announce IPO Targets as Cautious Optimism Propels Biotech Market
January 29, 2026
 · 
3 min read
 · 
Tristan Manalac
Facade of AstraZeneca's office in Shanghai, China
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
January 29, 2026
 · 
1 min read
 · 
Tristan Manalac